Eansor Norman David
SEC insider (Form 3/4/5 filer). CIK 0001270905. Director at Marker Therapeutics, Inc. (MRKR). 3 reported Form 4/5 transactions since Sep 2024; latest on Nov 17, 2025. Located in HOUSTON, TX.
Companies Eansor Norman David has filed insider reports for
- Marker Therapeutics, Inc. (MRKR): Director
Eansor Norman David
CIK: 0001270905
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MRKR
Marker Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Nov 17, 2025MRKR
Marker Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
84.4K shares- - Nov 17, 2025MRKR
Marker Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
137.3K shares- - Feb 12, 2025MRKR
Marker Therapeutics, Inc.
AwardDirectStock Option (right to buy)
30K shares-
1-3 of 3 transactions